Novartis CEO Says Company May Launch Drugs in Europe’s Private Markets
The CEO said Novartis will consider launching drugs in private markets in Europe if the impact of MFN on its US business is too high.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Novartis CEO Says It May Consider European Private-Market Drug Launches
Novartis’ CEO said the company will consider launching drugs in private markets in Europe if the impact of most-favored-nation policies on its U.S. business is too high.